Healthcare & Medical

18th International Conference on Malignant Lymphoma (ICML) 2025

The main aim of ICML is to facilitate the presentation of the most recent data on lymphoma - basic, translational, and clinical - and encourage the discussion among hematologists, clinical oncologists, radiation oncologists, pediatricians, pathologists, and leading researchers from all over the world.

Visit the official site
0Speakers
7Sponsors
0On the bill · sessions
7Companies · in total
§II

Sponsors

The houses behind the program. Tiers as disclosed.
Miltenyi BiomedicineSilver
AbbVieBronze
BeOne MedicinesBronze
Bristol Myers SquibbBronze
RocheBronze
Thermo Fisher ScientificBronze
Nurix TherapeuticsContributor
Intermission
Part the Second · For the Buyer

An audience of 7 companies, parsed from the program.

Seven companies in attendance.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room
0All threespeak · spons · exh
7Sponsoringsponsor only
0Companies Speakingspeaker only
Most-represented companies
  1. 01AbbVieSp·B
  2. 02BeOne MedicinesSp·B
  3. 03Bristol Myers SquibbSp·B
  4. 04Miltenyi BiomedicineSp·S
  5. 05Nurix TherapeuticsSp·C
  6. 06RocheSp·B
  7. 07Thermo Fisher ScientificSp·B
Sponsors by tier
silver1
14% of 7
bronze5
71% of 7
contributor1
14% of 7
At peer events but not here

These companies sponsored two or more peer events recently, but aren't on this program. For an organizer, that's a list of warm prospects.

Related events · by shared sponsors